The European Commission is today adopting new cooperation programmes worth €389 million in support of the Kingdom of Morocco, in order to support reforms, inclusive development and border management and work towards developing a ‘Euro-Moroccan partnership for shared prosperity’.
The High Representative of the Union for Foreign Affairs and Security Policy and Vice-President of the European Commission, Josep Borrell, stated that: ‘Morocco has long been an essential partner of the European Union (EU), with which we share borders and aspirations. Under the leadership of His Majesty, King Mohammed VI, Morocco has achieved significant steps towards modernisation and has made closer ties with Europe a strategic choice. Faced with shared challenges, the time has come to give new impetus to our relationship through deeper and more diversified cooperation, including towards Africa, in order to link our futures and bring our peoples closer together.
The Member of the European Commission in charge of Neighbourhood Policy and Enlargement, Olivér Várhelyi, stated that: ‘Morocco plays a crucial role as a partner of the European Union. Together, we will contribute to the sustainable and inclusive growth of Morocco, we will fight smuggler networks which endanger the lives of vulnerable people and we will improve the protection of migrant victims from these criminal networks. Morocco can count on the EU, our partnership will continue uninterrupted during my term of office.‘
As part of this strengthened cooperation, the new programmes include:
€289 million financed from the bilateral cooperation envelope to support Morocco’s reforms and inclusive development.
the signing of a financing agreement with Morocco for a budget support programme of €101.7 million supporting border management. The programme was adopted last week as part of the EU Emergency Trust Fund for Africa.
The Single Support Framework between the EU and Morocco has just been extended to 2019 and 2020
Morocco and the European Union have established a strong and dynamic partnership which has been steadily deepening since the year 2000 when the EU-Morocco Association Agreement entered into force. The special nature of the relationship between these two partners was recognised when Morocco was granted ‘advanced status’ in 2008. The Action Plan implementing the advanced status (2013-2018) was signed in December 2013 and provided specific guidelines for cooperation between the EU and Morocco. The Joint political declaration was adopted at the last EU-Morocco Association Council in June 2019. The new strategic priorities of the EU-Morocco partnership are expected to be defined in 2020.
Following comprehensive consultations with the government, civil society and various donors, and taking into account the government’s reform priorities and the principles of aid effectiveness, a consensus was reached regarding three priority intervention sectors to be financed through the 2014-2020 bilateral envelope with an indicative amount of between EUR 1.3 billion and EUR 1.6 billion. The priorities cover: i) Equitable access to basic services; ii) Support for democratic governance, the rule of law and mobility; iii) Employment and sustainable and inclusive growth.
Following the extension of the Single Support Framework, it was possible to adopt new programmes for cooperation between the EU and Morocco for a total of €289 million.
The EU is boosting its support for Morocco’s inclusive development
The objectives of the programmes that have just been adopted under the bilateral envelope for a total of €289 million are: i) improved access for vulnerable categories of people (rural population, social vulnerability, migrants, etc.) to education and vocational training; ii) the health sector, improvement of care and access to medicines in a context of advanced regionalisation; iii) better performance by the public administration to improve transparency and the efficiency of public services provision; iv) strengthened support for human rights; v) institutional support for the Moroccan Parliament.
The EU is boosting its support to Morocco for border management
The new budget support programme of €101.7 million as part of the North Africa strand of the EU Emergency Trust Fund for Africa will support border management and the fight against human trafficking. The programme will contribute to enhancing the management of land and sea borders, and also airports, by helping Morocco to continue modernising the means available to it, including by using new technologies and exchanging best practices with the EU agencies, Frontex and Europol. Respect for human rights and protection of vulnerable migrants will be at the heart of the programme, which includes training relating to these aspects. Given the high number of young people and unaccompanied minors from Morocco, the programme will put particular emphasis on raising the awareness of young people and their families concerning the perils of illegal migration. The analysis and collection of data on migration as part of the programme will contribute to providing the basis for a deeper partnership and dialogue with Morocco.
Coronavirus: EU Strategy for the development and availability of therapeutics
The European Commission is today complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID’. Today’s Strategy covers the full lifecycle of medicines: from research, development and manufacturing to procurement and deployment.
It is part of the strong European Health Union, in which all EU countries prepare and respond together to health crises and ensure the availability of affordable and innovative medical supplies – including the therapeutics needed to treat COVID-19.
The Strategy includes clear actions and targets, including authorising three new therapeutics to treat COVID-19 by October 2021 and possibly two more by end of the year. Concretely:
- Research, development and innovation
- Invest €90 million in population studies and clinical trials to establish links between risk factors and health outcomes to further inform public health policy and clinical management, including for long-COVID patients.
- Set up a ‘therapeutics innovation booster’ by July 2021 to support the most promising therapeutics from preclinical research to market authorisation. It will build on current initiatives and investments in therapeutic development, working in a close cooperation with the European Health Emergency Preparedness and Response Authority (HERA) preparatory action on mapping therapeutics. It will therefore ensure the coordination of all research projects on COVID-19 therapeutics, stimulating innovation and boosting therapeutic development.
- Access to and swift approval of clinical trials
- Invest €5 million under the EU4Health programme to generate better, high-quality safety data in clinical trials, which will help produce robust results in a timely manner.
- Provide EU countries with financial support of €2 million under the EU4Health 2021 work programme for expedited and coordinated assessments to facilitate approval of clinical trials.
- Explore how to support developers of therapeutics to build capacity to produce high-grade material for clinical trials.
- Scanning for candidate therapeutics
- Invest €5 million to map therapeutics and diagnostics to analyse development phases, production capacities and supply chains, including possible bottlenecks.
- Establish a broader portfolio of 10 potential COVID-19 therapeutics and identify five of the most promising ones by June 2021.
- Supply chains and delivery of medicines
- Fund a €40 million preparatory action to support flexible manufacturing and access for COVID-19 therapeutics under the EU Fab project, which in turn will become over time an important asset for the future the European Health Emergency Preparedness and Response Authority (HERA).
- Regulatory flexibility
- Authorise at least three new therapeutics by October and possibly two more by the end of the year and develop flexible regulatory approaches to speed up the assessment of promising and safe COVID-19 therapeutics.
- Start seven rolling reviews of promising therapeutics by end-2021, subject to research and development outcomes.
- Joint procurement and financing
- Launch new contracts for the purchase of authorised therapeutics by the end of the year.
- Secure faster access to medicines with shorter administrative deadlines.
- International cooperation to make medicines available to all
- Reinforce engagement for the therapeutics pillar of the Access to COVID-19 Tools Accelerator.
- Boost ‘OPEN’ initiative for international collaboration.
The Commission will draw up a portfolio of 10 potential COVID-19 therapeutics and by June 2021, identify the five most promising ones. It will organise matchmaking events for industrial actors involved in therapeutics to ensure enough production capacity and swift manufacturing. New authorisations, rolling reviews and joint procurement contracts will be up and running before the end of the year.
The therapeutics innovation booster, matchmaking events and preparatory action to support flexible manufacturing and access for COVID-19 therapeutics under the EU Fab project, will feed into the HERA, for which a proposal is due later in the year. The pilot project on access to health data will feed into the European Health Data Space proposal expected later this year.
Members of the College said:
Vice-President for Promoting our European Way of Life, Margaritis Schinas, said: “The situation in many intensive care units across the continent remains critical. We need to focus both on vaccines and therapeutics, as two powerful and complementary ways to combat COVID-19. But currently we have only one authorised medicine to treat COVID-19. By acting on better availability of medicines today, we are making sure patients receive the treatments they need while also preparing our future biomedical preparedness. A coordinated strategy on quick access to therapeutics will boost our strategic autonomy and contribute to a strong Health Union.”
Commissioner for Health and Food Safety, Stella Kyriakides, said: “Vaccinations save lives, but they cannot yet eradicate COVID-19. We need a strong push on treatments to limit the need for hospitalisation, speed up recovery times, and reduce mortality. Patients in Europe and across the world should have access to world-class COVID-19 medicines. This is why we have set a very clear goal: by October, we will develop and authorise three new effective COVID-19 therapeutics that can have the potential to change the course of the disease. We will do so by investing in research and innovation, the identification of new promising medicines, ramping up production capacity and supporting equitable access. Our Therapeutics Strategy is a strong European Health Union in action.”
Commissioner for Innovation, Research, Culture, Education and Youth, Mariya Gabriel, said: “By increasing vaccine availability across Europe, more and more Europeans are now protected against COVID-19. In the meantime, the development of innovative medicines to treat coronavirus patients remains a priority when it comes to saving lives. Research and innovation is the first step to finding effective and safe therapeutics, which is why we are proposing to establish a new COVID-19 ‘therapeutics innovation booster’ and will invest € 90 million in population studies and clinical trials.”
The Strategy on COVID-19 therapeutics complements the EU strategy for COVID-19 vaccines from June 2020 and builds on ongoing work by the European Medicines Agency and the Commission to support research, development, manufacturing and deployment of therapeutics.
The Strategy forms part of a strong European Health Union, using a coordinated EU approach to better protect the health of our citizens, equip the EU and its Member States to better prevent and address future pandemics, and improve the resilience of Europe’s health systems.
EU defence gets a boost as the European Defence Fund becomes a reality
Commission welcomes the adoption of the European Defence Fund (EDF), following the European Parliament’s approval. The EDF, with a budget of €7.9 billion, is the Commission’s flagship instrument to support defence cooperation in Europe. EDF will co-finance collaborative research and capability development projects amplifying national investment. It will also foster an innovative and competitive defence industrial base. In doing so, it will enhance Union’s technological sovereignty and therefore its open strategic autonomy.
Margrethe Vestager, Executive Vice-President for a Europe Fit for the Digital Age, said: “This is an important step for a stronger Europe. The Fund will play a key role to enable SMEs to participate in defence supply chains and widen cross-border industrial cooperation. Providing opportunities to companies all sizes helps achieving more innovative solutions, to foster an open internal market. So besides a stronger defence cooperation it contributes to our competitiveness.”
Thierry Breton, Commissioner for Internal Market, said: “Today marks a historic day for Europe. The idea of working together for promoting our Defence Union and for the security of EU citizens is now a tangible reality. In a global context where Europe needs to be stronger, more resilient and more autonomous in strategic areas, the European Defence Fund is a milestone and will significantly contribute to the security of EU citizens.”
A Fund to deepen EU defence industrial cooperation
Without substituting Member States’ efforts, the Fund will promote cooperation between companies of all sizes and research actors throughout the EU, in research and development of state-of-the-art and interoperable defence technology and equipment.
The Fund will support competitive and collaborative defence projects throughout the entire cycle of research and development, focusing on projects that have the potential to be game-changers for the armed forces of Member States. The Fund will foster innovation and incentivise the cross-border participation of SMEs. Projects will be defined based on defence capability priorities agreed by Member States within the framework of the Common Security and Defence Policy and particularly in the context of the Capability Development Plan. The projects will aim at contributing to the security and defence interests of the Union.
The EDF allows for the participation of European subsidiaries of third country companies and also for the cooperation with third country companies provided that their involvement ensure the security and defence interests of the EU, and meet the rigorous security conditions as set in the EDF Regulation.
A strong budget for ambitious and inclusive defence programmes
2021 constitutes the first year of the rollout of the new EDF, which will be operational for the period 2021-2027, in alignment with the Multiannual Financial Framework.
It will be endowed with a budget of €7,953,000,000 in current prices. This financial envelope will be divided into two pillars: €2,651,000,000 will be allocated to funding collaborative defence research to address emerging and future security threats and €5,302,000,000 to co-finance collaborative capability development projects.
Up to 4%-8% of the Fund budget is devoted to development or research for disruptive technologies (i.e. technologies that have the potential to create game-changing innovations). This budget represents an unprecedented opportunity to contribute to the development of a competitive and innovative European defence industry.
The complete establishment of the Fund both legally and financially will now allow the Programme Committee (PC), chaired by the Commission and composed of Member States representatives, to discuss priorities and confront topics with the aim to open calls for proposals in summer 2021. The Commission will directly manage the programme. The European Defence Agency (EDA) is invited to participate as observer and the European External Action Service (EEAS) will assist in the Committee.
The creation of a European Defence Fund was first announced in 2016. The Commission presented the first version of the European Defence Fund in June 2017, which has allowed defence cooperation at EU level to embark thanks to two pilot projects, the Preparatory Action on Defence Research (PADR) for 2017-2019 and the European Defence Industrial Development Programme (EDIDP) for 2019-2020.
The Fund is part of the priorities of the von der Leyen Commission for a ‘Stronger Europe in the World’.
A political agreement between the Member States and the European Parliament was found in December 2020 and today’s decision gives legislative effect to the EDF that will operate for the next 7 years.
Dual-use goods: what are they and why are new rules needed?
The EU is working on new export rules for so-called dual-use goods to prevent them being misused in human rights violations.
What are dual-use goods?
Dual-use products are goods designed for civilian use that in the wrong hands could be used to supress human rights or launch terrorist attacks. They can be anything from drones to chemicals.
Although these goods can improve people’s lives, they can be misused. Authoritarian regimes might use them to keep the population under control, while terrorist groups could use them to stage attacks.
Why are new rules needed?
To prevent dual-use goods being repurposed in ways that violate human rights , the EU wants to make sure strict export rules prevent them being sold to people or organisations wanting to misuse them.
The EU is currently working on an update of the existing rules to take into account recent technological developments, including new cyber surveillance tools, and beef up protection of human rights.
Weakness or calculation? How the pandemic undermined the US world leadership
Anyone watching the numerous doomsday movies, happily churned out by Hollywood, will see American doctors saving the planet from space-borne...
Prospects for a Settlement of the Libyan Conflict: Three Scenarios of the Mid-Term Forecast
More than ten years ago, in February 2011, the Arab Spring began in Libya. The armed uprising quickly escalated into...
Discerning the Human Element Amid the Pandemic
“We are not human beings having a spiritual experience. We are spiritual beings having a human experience.” – Pierre Teilhard de...
“Kharibulbul” festival represents a multi-ethnic, multi-confessional and multicultural Azerbaijan
As a country of multiculturalism, Azerbaijan promotes the cross-cultural dialogue inside the country, but also at the regional level. The...
A leaderless ship: The Bulgaria’s political crisis and the storm to come
Internal and international tensions Politics tends to develop in a complex conundrum in all Balkan countries. Thus, never can observers...
Elon Musk’s “City-State” on Mars: An International Problem
The private space industry is booming with companies like SpaceX, Blue Origin, and Virgin Galactic all designing spacecraft to transport...
Feminist perspective of the War,Peace and Politics in International Relations
India is a land where Mahatma Gandhi and his ideas of non-violence were born, but it is also the land...
East Asia3 days ago
China’s Navy in the Arctic: Potential Game Changer for the Future of the Region?
Middle East2 days ago
Israel-Palestine Conflict Enters into Dangerous Zone
Europe3 days ago
Serbia’s EU accession: Pipe Dream or Possible Reality?
Energy3 days ago
Is it finally time for hydrogen?
Europe3 days ago
The Idea of Global Britain: A Neo-Victorian Attempt to Define the Place of the English in the World
Eastern Europe2 days ago
Baltic States are the territories of geopolitical games
International Law3 days ago
Basic knowledge about Peace Education and how it is beneficial in resolving conflicts
Defense3 days ago
The Irony of Afghanistan: US Plans Departure amidst Anarchy